Todd C. Skaar

1. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
   2021/01/02 by Kristine R. Crews, Andrew A. Monte, Rachel Huddart +18 · 3 citations
   Medicine · Pharmacology, Toxicology and Pharmaceutics · #Diet and metabolism studies #Pharmaceutical studies and practices #Pharmacogenetics and Drug Metabolism
2. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
   2011/12/28 by Kristine R. Crews, Andrea Gaedigk, Henry M. Dunnenberger +5 · 4 citations
   Pharmacology, Toxicology and Pharmaceutics · Medicine · #Pharmacogenetics and Drug Metabolism #Cancer Treatment and Pharmacology #Pain Management and Opioid Use
3. Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
   2014/01/23 by Kristine R. Crews, Andrea Gaedigk, Henry M. Dunnenberger +10 · 2 citations
   Pharmacology, Toxicology and Pharmaceutics · Medicine · #Pharmacogenetics and Drug Metabolism #Cancer Treatment and Pharmacology #Pain Management and Opioid Use
4. Molecular and pharmacological aspects of antiestrogen resistance
   2001/03/01 by Robert Clarke, Todd C. Skaar, Kerrie B. Bouker +4 · 1 citation
   Biochemistry, Genetics and Molecular Biology · Computer Science · Pharmacology, Toxicology and Pharmaceutics · #Computational Drug Discovery Methods #Estrogen and related hormone effects #Medicinal Plant Pharmacodynamics Research